Cargando…

Effectiveness and safety of an extended‐release tablet of sodium valproate for the prophylactic treatment of migraine: Postmarketing surveillance in Japan

BACKGROUND: Sodium valproate is a standard drug for first‐line prophylactic treatment of migraine. However, little information is available of its use in Japanese patients. AIM: To evaluate the effectiveness and safety of an extended‐release tablet of sodium valproate in the prophylactic treatment f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takeshima, Takao, Suzuki, Norihiro, Matsumori, Yasuhiko, Shimmoto, Naoki, Kurihara, Yuji, Gunji, Ryoji, Sakai, Fumihiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5074326/ https://www.ncbi.nlm.nih.gov/pubmed/27818772 http://dx.doi.org/10.1111/ncn3.12053

Ejemplares similares

Clinical Response to Valproate in Patients with Migraine
por: Ichikawa, Mizuki, et al.
Publicado: (2016)

Erenumab treatment for migraine prevention in Japanese patients: Efficacy and safety results from a Phase 3, randomized, double‐blind, placebo‐controlled study
por: Takeshima, Takao, et al.
Publicado: (2021)

Dalfampridine extended release tablets: 1 year of postmarketing safety experience in the US
por: Jara, Michele, et al.
Publicado: (2013)

Japanese study of tofogliflozin with type 2 diabetes mellitus patients in an observational study of the elderly (J‐STEP/EL): A 12‐week interim analysis
por: Utsunomiya, Kazunori, et al.
Publicado: (2016)

Efficacy and safety of erenumab in Japanese migraine patients with prior preventive treatment failure or concomitant preventive treatment: subgroup analyses of a phase 3, randomized trial
por: Hirata, Koichi, et al.
Publicado: (2021)

Burden of Migraine in Japan: Results of the ObserVational Survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) Study
por: Matsumori, Yasuhiko, et al.
Publicado: (2021)

Rapid Onset and Sustained Efficacy of Lasmiditan Among Japanese Patients with Migraine: Prespecified Analyses of a Randomized Controlled Trial
por: Matsumori, Yasuhiko, et al.
Publicado: (2022)

Safety and effectiveness of tofogliflozin in elderly Japanese patients with type 2 diabetes mellitus: A post‐marketing study (J‐STEP/EL Study)
por: Utsunomiya, Kazunori, et al.
Publicado: (2017)

Early onset of efficacy with erenumab for migraine prevention in Japanese patients: Analysis of two randomized, double‐blind, placebo‐controlled studies
por: Hirata, Koichi, et al.
Publicado: (2022)

Outcomes and Factors Associated with Insufficient Effectiveness of Acute Treatments of Migraine in Japan: Results of the ObserVational survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) Study
por: Hirata, Koichi, et al.
Publicado: (2023)

Potential Unmet Needs in Acute Treatment of Migraine in Japan: Results of the OVERCOME (Japan) Study
por: Takeshima, Takao, et al.
Publicado: (2022)

Phase 2 randomized placebo‐controlled study of lasmiditan for the acute treatment of migraine in Japanese patients
por: Sakai, Fumihiko, et al.
Publicado: (2021)

Risk of hypertension in erenumab‐treated patients with migraine: Analyses of clinical trial and postmarketing data
por: Dodick, David W., et al.
Publicado: (2021)

Efficacy and safety of fremanezumab for chronic migraine prevention: Multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group trial in Japanese and Korean patients
por: Sakai, Fumihiko, et al.
Publicado: (2021)

Comparison of prophylactic response to lithium and valproate in patients with Early Onset Bipolar Disorder
por: Purkayastha MUKHERJEE, M., et al.
Publicado: (2023)

Preparation of Coated Valproic Acid and Sodium Valproate Sustained-release Matrix Tablets
por: Phaechamud, T., et al.
Publicado: (2010)

A Randomized Phase 2 Study of Erenumab for the Prevention of Episodic Migraine in Japanese Adults
por: Sakai, Fumihiko, et al.
Publicado: (2019)

Prophylactic treatment of vestibular migraine()
por: Salmito, Márcio Cavalcante, et al.
Publicado: (2016)

Long‐term efficacy and safety during open‐label erenumab treatment in Japanese patients with episodic migraine
por: Sakai, Fumihiko, et al.
Publicado: (2021)

Naratriptan May Become an Alternative Prophylactic Option for Patients with Cluster Headache
por: Kikui, Shoji, et al.
Publicado: (2017)

A study to investigate the prevalence of headache disorders and migraine among people registered in a health insurance association in Japan
por: Sakai, Fumihiko, et al.
Publicado: (2022)

Correction: A study to investigate the prevalence of headache disorders and migraine among people registered in a health insurance association in Japan
por: Sakai, Fumihiko, et al.
Publicado: (2022)

Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis
por: Koike, Takao, et al.
Publicado: (2011)

Cinnarizine in refractory migraine prophylaxis: efficacy and tolerability. A comparison with sodium valproate
por: Togha, Mansoureh, et al.
Publicado: (2008)

Randomized Clinical Trial of Intravenous Valproate (Orifil) and Dexamethasone in Patients with Migraine Disorder
por: Foroughipour, Mohsen, et al.
Publicado: (2013)

Cinnarizine in refractory migraine prophylaxis: efficacy and tolerability. A comparison with sodium valproate
por: Mansoureh, Togha, et al.
Publicado: (2008)

Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patients
por: Koike, Takao, et al.
Publicado: (2011)

Postmarketing surveillance of the safety and effectiveness of abatacept in Japanese patients with rheumatoid arthritis
por: Harigai, Masayoshi, et al.
Publicado: (2016)

Advances in topiramate as prophylactic treatment for migraine
por: Hu, Chuan, et al.
Publicado: (2021)

Migraine in the workplace
por: Begasse de Dhaem, Olivia, et al.
Publicado: (2022)

Comparative study of magnesium, sodium valproate, and concurrent magnesium-sodium valproate therapy in the prevention of migraine headaches: a randomized controlled double-blind trial
por: Khani, Samira, et al.
Publicado: (2021)

Rapid improvement of a complex migrainous episode with sodium valproate in a patient with CADASIL
por: Martikainen, Mika H., et al.
Publicado: (2011)

Comparison of Levetiracetam and sodium Valproate in migraine prophylaxis: A randomized placebo-controlled study
por: Sadeghian, Homa, et al.
Publicado: (2015)

Comparison of Pregabalin and Sodium Valproate in Migraine Prophylaxis: A Randomized Double-Blinded Study
por: Hesami, Omid, et al.
Publicado: (2018)

Comparing Pregabalin and Sodium Valproate in Pediatric Migraine Prophylaxis: A Randomized Clinical Trial
por: JAFARI, Narjes, et al.
Publicado: (2023)

Naratriptan in the Prophylactic Treatment of Cluster Headache
por: Ito, Yasuo, et al.
Publicado: (2017)

Sleep changes during prophylactic treatment of migraine
por: Duman, Taşkın, et al.
Publicado: (2015)

Vitamin Supplementation as Possible Prophylactic Treatment against Migraine with Aura and Menstrual Migraine
por: Shaik, Munvar Miya, et al.
Publicado: (2015)

Efficacy of Lasmiditan Across Patient and Migraine Characteristics in Japanese Patients with Migraine: A Secondary Analysis of the MONONOFU Trial
por: Takeshima, Takao, et al.
Publicado: (2022)

Safety profile of dalfampridine extended release in multiple sclerosis: 5-year postmarketing experience in the United States
por: Jara, Michele, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7332f9j2e8mcktu7n1gm09daft